Due to the high levels of ASGPR expression in the hepatic cancer tissue, these receptors offer an improved choice for delivery of drugs in the treatment of HCC (Makadia, H.K. and Siegel, S.J., 2011; Huang, K.W., et al., 2018). The gene discussed is ASGR1; the disease is hepatocellular carcinoma.